Mediastinal lymph node involvement in non-small cell lung cancer: Evaluation with 99mTc-tetrofosmin SPECT and comparison with CT

Journal of Nuclear Medicine

Volumn 44, Issue 8, 2003, Pages 1219-1224

  Schillaci, Orazio ^a,d   Spanu, Angela ^b   Scopinaro, Francesco ^c   Monteleone, Francesco ^c   Solinas, Maria Elisabetta ^b   Volpino, Patrizia ^c   Pirina, Pietro ^b   Marongiu, Pietro ^b   Cangemi, Vincenzo ^c   Madeddu, Giuseppe ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NONE   (Italy)

Author keywords

99mTc tetrofosmin; CT; Mediastinal lymph nodes; Non small cell lung cancer; SPECT

Indexed keywords

TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG UPTAKE; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; THORACOTOMY; THORAX; TIME; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; LUNG TUMOR; MEDIASTINUM TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PREOPERATIVE CARE; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0141781305     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Lloyd C, Silvestri GA. Mediastinal staging of non-small-cell lung cancer. Cancer Control. 2001;8:311-317.
3. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol. 2000;18:106-115.
4. Shepherd FA Induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac Surg 1993;55:1585-1592
5. Rusch VW, Albain KS, Crowley JJ, et al. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy: a Southwest Oncology Group trial J Thorac Cardiovasc Surg. 1993;105: 97-104.
6. Staples CA, Muller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma comparison between CT and mediastinoscopy Radiology 1988;167:367-372.
7. Friedman PJ Lung cancer staging: efficacy of CT. Radiology. 1992;182:307-309.
8. Brown JS, Rudd R. New staging investigations for lung cancer what will they have to offer to be clinically useful? Eur J Nucl Med. 1995;22:497-498.
9. van Tinteren H, Hoekstra OS, Smit EF, et al Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre trial. Lancet. 2002;359:1388-1392.
10. 201Tl SPECT in the detection of mediastinal lymph node metastases from lung cancer. Nucl Med Commun. 1991;12: 779-792.
11. Yokoi K, Okuyama A, Mori K, et al. Mediastinal lymph node metastasis from lung cancer: evaluation with Tl-201 SPECT - comparison with CT. Radiology. 1994;192:813-817.
12. Chiti A, Maffioli LS, Infante M, et al. Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT. J Nucl Med. 1996;37:938-942.
13. Nosotti M, Santambrogio L, Gasparini M, Baisi A, Bellaviti N, Rosso L. Role of Tc-99m MIBI in the diagnosis and staging of lung cancer. Chest. 2002;122:1361-1364
14. Higley B, Smith FW, Smith T, et al Technetium-99m-1,2-bis[bis(2- ethoxyethyl) phosphino]ethane, human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.
15. Wackers FJT, Berman DS, Maddahi J, et al Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989;30:301-311.
16. Shomacker K, Schicha H. Use of myocardial imaging agents for tumour diagnosis a success story? Eur J Nucl Med 2000;27:1845-1863
17. 201Tl. Nucl Med Commun. 1997; 18:341-345
18. 99mTc-tetrofosmin chest imaging. J Nucl Med. 2001;42:17-20
19. Lau CL, Harpole DH. Noninvasive clinical staging modalities for lung cancer. Semin Surg Oncol. 2000;18:116-123
20. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology. 1994;191:371-377.
21. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178:705-713.
22. Chiti A, Schreiner FA, Crippa F, Pauwels EK, Bombardieri E. Nuclear medicine procedures m lung cancer. Eur J Nucl Med. 1999;26:533-555
23. Gambhir SS, Gupta P, Allen P, Hoh C, Maddhai J, Phelps ME. A simulation tool for modeling cost effectiveness with applications for determining the cost effective role of nuclear medicine studies in lung and breast cancer. J Nucl Med. 1996;37:1428-1434
24. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m- tetrofosmin, technetium-99m-mibi and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-1556
25. Shiun SC, Sun SS, Hsu NY, Kao CH, Lin CC, Lee CC. Detecting mediastinal lymph node metastases in non-small-cell lung cancer using a combination of technetium-99m tetrofosmin chest single photon emission computed tomography and chest computed tomography Cancer Invest. 2002;20:311-317.
26. 99mTc-Tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations. Cancer. 2002;94:1796-1807.
27. Bernstein MP, Caldwell CB, Antonyshyn OM, Cooper PW, Ehrlich LE. Spatial and temporal registration of CT and SPECT images: development and validation of a technique for in vivo three-dimensional semiquantitative analysis of bone J Nucl Med. 2000;41:1075-1081.
28. Katyal S, Kramer EL, Noz ME, McCauley D, Chachoua A, Steineld A. Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer Cancer Res 1995;55(23 suppl):5759s-5763s
29. Bocher M, Balan A, Krausz Y, et al. Gamma camera-mounted anatomical x-ray tomography technology, system characteristics and first images. Eur J Nucl Med. 2000;27:619-627.
30. Schillaci O, Danieli R, Picardi V, et al. A combined SPET/CT imaging system for functional anatomical mapping: initial clinical applications [abstract] Eur J Nucl Med. 2002;29(suppl 1):S94.